Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 45

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Quaternary structure of the specific p53–DNA complex reveals the mechanism of p53 mutant dominance

Aramayo, Ricardo, Sherman, Michael B., Brownless, Kathryne, Lurz, Rudi, Okorokov, Andrei L., Orlova, Elena V. · 2011 · Nucleic Acids Research

Abstract

The p53 tumour suppressor is a transcriptional activator that controls cell fate in response to various stresses. p53 can initiate cell cycle arrest, senescence and/or apoptosis via transactivation of p53 target genes, thus preventing cancer onset. Mutations that impair p53 usually occur in the core domain and negate the p53 sequence-specific DNA binding. Moreover, these mutations exhibit a dominant negative effect on the remaining wild-type p53. Here, we report the cryo electron microscopy structure of the full-length p53 tetramer bound to a DNA-encoding transcription factor response element (RE) at a resolution of 21 A. While two core domains from both dimers of the p53 tetramer interact with DNA within the complex, the other two core domains remain available for binding another DNA site. This finding helps to explain the dominant negative effect of p53 mutants based on the fact that p53 dimers are formed co-translationally before the whole tetramer assembles; therefore, a single mutant dimer would prevent the p53 tetramer from binding DNA. The structure indicates that the Achilles' heel of p53 is in its dimer-of-dimers organization, thus the tetramer activity can be negated by mutation in only one allele followed by tumourigenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkr386

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. EM of p53–DNA complexes. (A) Schematic representation of the DNA with 13 consecutive CON (RE) sequences used for p53–DNA binding experiments. (B–D) EM images of p53–DNA complexes rotary shadowed with Pt-Ir. White and black arrows show DNA and p53, respectively. (D) In these images, a single-p53 tetramer is seen bound to two DNA strands. Scale bars 500 Å. (E) Cryo EM images of p53–DNA complexes showing that the DNA-bound protein particles resemble ‘beads on a string’. Circles indicate p53 tetramers attached to DNA (grey line). Scale bar 200 Å.
Figure 1. EM of p53–DNA complexes. (A) Schematic representation of the DNA with 13 consecutive CON (RE) sequences used for p53–DNA binding experiments. (B–D) EM images of p53–DNA complexes rotary shadowed with Pt-Ir. White and black arrows show DNA and p53, respectively. (D) In these images, a single-p53 tetramer is seen bound to two DNA strands. Scale bars 500 Å. (E) Cryo EM images of p53–DNA complexes showing that the DNA-bound protein particles resemble ‘beads on a string’. Circles indicate p53 tetramers attached to DNA (grey line). Scale bar 200 Å.CC BY-NC · PubMed Central
Figure 2. 3D reconstruction of the p53–DNA complex. (A) Side and top views of the p53–DNA complex. (B) Superimposition of the DNA-free p53 map (gold) on the p53–DNA complex map (blue–grey). The two maps were compared in order to determine the location of core domains and dimers within the complex. N/C—areas of N- and C-termini interaction. The length of the stem corresponding to DNA is limited by the size of the image frames. (C) Stereo view of the crystal structure of two core domains bound to DNA RE (PDB entry: 2ata) fitted into the upper part of the map (threshold used: 2σ, light grey). Core domains are displayed in orange and DNA in red. (D) Fitting of the core domains and DNA in the EM map. Core domains are displayed in blue and red, DNA in orange. The high EM densities are shown in light blue at 4σ. Fits were performed with both Chimera and Veda/UROX. The best fits from each software produced similar results.
Figure 2. 3D reconstruction of the p53–DNA complex. (A) Side and top views of the p53–DNA complex. (B) Superimposition of the DNA-free p53 map (gold) on the p53–DNA complex map (blue–grey). The two maps were compared in order to determine the location of core domains and dimers within the complex. N/C—areas of N- and C-termini interaction. The length of the stem corresponding to DNA is limited by the size of the image frames. (C) Stereo view of the crystal structure of two core domains bound to DNA RE (PDB entry: 2ata) fitted into the upper part of the map (threshold used: 2σ, light grey). Core domains are displayed in orange and DNA in red. (D) Fitting of the core domains and DNA in the EM map. Core domains are displayed in blue and red, DNA in orange. The high EM densities are shown in light blue at 4σ. Fits were performed with both Chimera and Veda/UROX. The best fits from each software produced similar results.CC BY-NC · PubMed Central
Figure 3. Structural organization of the DNA-p53 complex. (A) Each dimer is depicted as a rectangular plane that packs face-to-face to form the p53 tetramer. Three possible arrangements of the interaction of this p53 tetramer with DNA are shown: (i) in this arrangement only the two core domains of the blue dimer interface with DNA (orange rod). In (ii) and (iii) domains from two different dimers (blue and red) interact with DNA, but in two possible configurations: in (ii) the shorter edges of the rectangular dimers are oriented along the DNA helix whereas in (iii) the DNA helix lies across these edges. Positions of N- and C-termini, indicated as N and C accordingly, are shown as light and dark rods of the same colour along the edges of the dimer planes. (B and C) Stereo views of p53 dimers within the map, corresponding to model (ii). The dimer at the front is in blue, and at the back is in red, and the DNA in orange. The positions of the N- and C-termini are shown in different shades of blue. Two of the C-termini domains are located just below the DNA, and the other two are at the bottom of the structure. Positions of C-termini in the core domains are indicated with Ctc.
Figure 3. Structural organization of the DNA-p53 complex. (A) Each dimer is depicted as a rectangular plane that packs face-to-face to form the p53 tetramer. Three possible arrangements of the interaction of this p53 tetramer with DNA are shown: (i) in this arrangement only the two core domains of the blue dimer interface with DNA (orange rod). In (ii) and (iii) domains from two different dimers (blue and red) interact with DNA, but in two possible configurations: in (ii) the shorter edges of the rectangular dimers are oriented along the DNA helix whereas in (iii) the DNA helix lies across these edges. Positions of N- and C-termini, indicated as N and C accordingly, are shown as light and dark rods of the same colour along the edges of the dimer planes. (B and C) Stereo views of p53 dimers within the map, corresponding to model (ii). The dimer at the front is in blue, and at the back is in red, and the DNA in orange. The positions of the N- and C-termini are shown in different shades of blue. Two of the C-termini domains are located just below the DNA, and the other two are at the bottom of the structure. Positions of C-termini in the core domains are indicated with Ctc.CC BY-NC · PubMed Central
Figure 4. Rearrangement of domains within the p53 tetramer upon DNA binding. (A) Stereo (side and front) views of a superposition of one top core domain from the p53–DNA complex EM map (blue) and the core from an aligned DNA-free EM map (yellow). The relative rotation between the cores is shown with a red arrow. (B) Schematic representation of p53 in the DNA-free state (left) and DNA-bound complex (right). In the DNA-free state the p53 tetramer is represented as a pair of red and blue dimers. When interacting with specific DNA sequences the two dimers rotate relative to each other (red and blue arrows, left panel) bringing the upper two core domains closer to enable interactions with DNA.
Figure 4. Rearrangement of domains within the p53 tetramer upon DNA binding. (A) Stereo (side and front) views of a superposition of one top core domain from the p53–DNA complex EM map (blue) and the core from an aligned DNA-free EM map (yellow). The relative rotation between the cores is shown with a red arrow. (B) Schematic representation of p53 in the DNA-free state (left) and DNA-bound complex (right). In the DNA-free state the p53 tetramer is represented as a pair of red and blue dimers. When interacting with specific DNA sequences the two dimers rotate relative to each other (red and blue arrows, left panel) bringing the upper two core domains closer to enable interactions with DNA.CC BY-NC · PubMed Central
Figure 5. p53 DNA binding and the effect of mutations. (A) Schematic representation of DNA looping by p53. Two distal REs are bound to two pairs of cores located on opposite sides of a single-p53 tetramer. (B) Suppression of p53 activity by cancer-associated mutations. As p53 dimers are formed co-translationally (24), half of the dimers would be of wt with both core domains active (open circles) and the other half would be inactive dimers, with mutated core domains (shaded circles). If both dimers are translated at equal levels, they could form three different types of tetramers with corresponding probabilities: 25% wt/wt, 50% wt/mut and 25% mut/mut. In our structure, where each dimer within the p53 tetramer contributes one core domain to specific DNA binding, only one type of tetramer (wt/wt) would be functional. Therefore once one allele of p53 is mutated in the DNA binding region, it would render inactive 75% of p53 tetramers, which is in agreement with observed in vivo dominant negative effect of p53 mutations (48).
Figure 5. p53 DNA binding and the effect of mutations. (A) Schematic representation of DNA looping by p53. Two distal REs are bound to two pairs of cores located on opposite sides of a single-p53 tetramer. (B) Suppression of p53 activity by cancer-associated mutations. As p53 dimers are formed co-translationally (24), half of the dimers would be of wt with both core domains active (open circles) and the other half would be inactive dimers, with mutated core domains (shaded circles). If both dimers are translated at equal levels, they could form three different types of tetramers with corresponding probabilities: 25% wt/wt, 50% wt/mut and 25% mut/mut. In our structure, where each dimer within the p53 tetramer contributes one core domain to specific DNA binding, only one type of tetramer (wt/wt) would be functional. Therefore once one allele of p53 is mutated in the DNA binding region, it would render inactive 75% of p53 tetramers, which is in agreement with observed in vivo dominant negative effect of p53 mutations (48).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 54

  1. Vogelstein, 2000, Surfing the p53 network, Nature, 408, 307, 10.1038/35042675 · DOI · Paper page
  2. Oren, 2003, Decision making by p53: life, death and cancer, Cell Death Differ., 10, 431, 10.1038/sj.cdd.4401183 · DOI · Paper page
  3. Murray-ZmijewskI, 2008, A complex barcode underlies the heterogeneous response of p53 to stress, Nat. Rev. Mol. Cell Biol., 9, 702, 10.1038/nrm2451 · DOI · Paper page
  4. Vousden, 2009, Blinded by the Light: The Growing Complexity of p53, Cell, 137, 413, 10.1016/j.cell.2009.04.037 · DOI · Paper page
  5. Vousden, 2007, p53 in health and disease, Nat. Rev. Mol. Cell. Biol., 8, 275, 10.1038/nrm2147 · DOI · Paper page
  6. Parant, 2003, Disrupting TP53 in mouse models of human cancers, Hum. Mutat., 21, 321, 10.1002/humu.10186 · DOI
  7. Royds, 2006, p53 and disease: when the guardian angel fails, Cell Death Differ., 13, 1017, 10.1038/sj.cdd.4401913 · DOI · Paper page
  8. Bakalkin, 1995, p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain, Nucleic Acids Res., 23, 362, 10.1093/nar/23.3.362 · DOI · Paper page
  9. Lee, 1995, p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches, Cell, 81, 1013, 10.1016/S0092-8674(05)80006-6 · DOI · Paper page
  10. Cain, 2000, The N terminus of p53 regulates its dissociation from DNA, J. Biol. Chem., 275, 39944, 10.1074/jbc.M002509200 · DOI
  11. Espinosa, 2001, Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment, Mol. Cell, 8, 57, 10.1016/S1097-2765(01)00283-0 · DOI · Paper page
  12. McKinney, 2002, Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein, Mol. Cell Biol., 22, 6797, 10.1128/MCB.22.19.6797-6808.2002 · DOI
  13. McKinney, 2004, p53 linear diffusion along DNA requires its C terminus, Mol. Cell, 16, 413, 10.1016/j.molcel.2004.09.032 · DOI · Paper page
  14. Joerger, 2007, Structural biology of the tumor suppressor p53 and cancer-associated mutants, Adv. Cancer Res., 97, 1, 10.1016/S0065-230X(06)97001-8 · DOI · Paper page
  15. Okorokov, 2009, Structural biology of the p53 tumour suppressor, Curr. Opin. Struct. Biol., 19, 197, 10.1016/j.sbi.2009.02.003 · DOI
  16. Kern, 1991, Identification of p53 as a sequence-specific DNA-binding protein, Science, 252, 1708, 10.1126/science.2047879 · DOI · Paper page
  17. Tokino, 1994, p53 tagged sites from human genomic DNA, Hum. Mol. Genet., 3, 1537, 10.1093/hmg/3.9.1537 · DOI · Paper page
  18. Harris, 2009, p53 responsive elements in human retrotransposons, Oncogene, 28, 3857, 10.1038/onc.2009.246 · DOI · Paper page
  19. Kim, 2006, The versatile interactions of p53 with DNA: when flexibility serves specificity, Cell Death Differ., 13, 885, 10.1038/sj.cdd.4401909 · DOI
  20. Wang, 1995, Interaction of p53 with its consensus DNA-binding site, Mol. Cell Biol., 15, 2157, 10.1128/MCB.15.4.2157 · DOI
  21. Nicholls, 2002, Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers. Implications on the dominant negative effect, J. Biol. Chem., 277, 12937, 10.1074/jbc.M108815200 · DOI
  22. Zhao, 2001, Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution, J. Biol. Chem., 276, 12120, 10.1074/jbc.M011644200 · DOI
  23. Kitayner, 2006, Structural basis of DNA recognition by p53 tetramers, Mol. Cell, 22, 741, 10.1016/j.molcel.2006.05.015 · DOI · Paper page
  24. Varley, 1997, A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene, Oncogene, 14, 865, 10.1038/sj.onc.1201041 · DOI
  25. Okorokov, 2006, The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity, EMBO J., 25, 5191, 10.1038/sj.emboj.7601382 · DOI · Paper page
  26. Tidow, 2007, Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex, Proc. Natl Acad. Sci. USA, 104, 12324, 10.1073/pnas.0705069104 · DOI · Paper page
  27. Melero, 2011, Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA, Proc. Natl Acad. Sci. USA, 108, 557, 10.1073/pnas.1015520107 · DOI · Paper page
  28. Hyatt, 2000, Principles and techniques of electron microscopy: biological applications, 543
  29. Ludtke, 1999, EMAN: semiautomated software for high-resolution single-particle reconstructions, J. Struct. Biol., 128, 82, 10.1006/jsbi.1999.4174 · DOI · Paper page
  30. Mindell, 2003, Accurate determination of local defocus and specimen tilt in electron microscopy, J. Struct. Biol., 142, 334, 10.1016/S1047-8477(03)00069-8 · DOI · Paper page
  31. van Heel, 1996, A new generation of the IMAGIC image processing system, J. Struct. Biol., 116, 17, 10.1006/jsbi.1996.0004 · DOI · Paper page
  32. van Heel, 2000, Single-particle electron cryo-microscopy: towards atomic resolution, Q. Rev. Biophys., 33, 307, 10.1017/S0033583500003644 · DOI · Paper page
  33. Scheres, 2009, Averaging of electron subtomograms and random conical tilt reconstructions through likelihood optimization, Structure, 17, 1563, 10.1016/j.str.2009.10.009 · DOI
  34. Pettersen, 2004, UCSF Chimera - A visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 · DOI · Paper page
  35. Siebert, 2009, UROX 2.0: an interactive tool for fitting atomic models into electron-microscopy reconstructions, Acta Crystallogr. D Biol. Crystallogr., 65, 651, 10.1107/S0907444909008671 · doi:10.1107/s0907444909008671
  36. Jeffrey, 1995, Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms, Science, 267, 1498, 10.1126/science.7878469 · DOI · Paper page
  37. Collaborative Computational Project, Number 4, 1994, The CCP4 suite: programs for protein crystallography, Acta Crystallogr. D Biol. Crystallogr., 50, 760, 10.1107/S0907444994003112 · DOI · Paper page
  38. Milner, 1991, Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation, Cell, 65, 765, 10.1016/0092-8674(91)90384-B · DOI · Paper page
  39. Hupp, 1994, Allosteric activation of latent p53 tetramers, Curr. Biol., 4, 865, 10.1016/S0960-9822(00)00195-0 · DOI · Paper page
  40. Kellenberger, 1982, The wrapping phenomenon in air-dried and negatively stained preparations, Ultramicroscopy, 9, 139, 10.1016/0304-3991(82)90236-4 · DOI
  41. Malecka, 2009, Crystal structure of a p53 core tetramer bound to DNA, Oncogene, 28, 325, 10.1038/onc.2008.400 · DOI
  42. Jiao, 2001, Dynamic interactions of p53 with DNA in solution by time-lapse atomic force microscopy, J. Mol. Biol., 314, 233, 10.1006/jmbi.2001.5129 · DOI
  43. Popovych, 2009, Structural basis for cAMP-mediated allosteric control of the catabolite activator protein, Proc. Natl Acad. Sci. USA, 106, 6927, 10.1073/pnas.0900595106 · DOI · Paper page
  44. Levy, 2008, Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator, Mol. Microbiol., 70, 151, 10.1111/j.1365-2958.2008.06399.x · DOI
  45. Berg, 1981, Diffusion-driven mechanisms of protein translocation on nucleic acids. 1. Models and theory, Biochemistry, 20, 6929, 10.1021/bi00527a028 · DOI · Paper page
  46. Waterman, 1995, The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding, EMBO J., 14, 512, 10.1002/j.1460-2075.1995.tb07027.x · DOI
  47. Stenger, 1994, p53 oligomerization and DNA looping are linked with transcriptional activation, EMBO J., 13, 6011, 10.1002/j.1460-2075.1994.tb06947.x · DOI · Paper page
  48. Jackson, 1998, Synergistic transcriptional activation of the MCK promoter by p53: tetramers link separated DNA response elements by DNA looping, Oncogene, 16, 283, 10.1038/sj.onc.1201491 · DOI
  49. Harvey, 1995, A mutant p53 transgene accelerates tumour development in hetero zygous but not nulli zygous p53-deficient mice, Nat. Genet., 9, 305, 10.1038/ng0395-305 · DOI · Paper page
  50. Liu, 2000, High metastatic potential in mice inheriting a targeted p53 missense mutation, Proc. Natl Acad. Sci. USA, 97, 4174, 10.1073/pnas.97.8.4174 · DOI · Paper page
  51. de Vries, 2002, Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function, Proc. Natl Acad. Sci. USA, 99, 2948, 10.1073/pnas.052713099 · DOI · Paper page
  52. Chène, 2001, The role of tetramerization in p53 function, Oncogene, 20, 2611, 10.1038/sj.onc.1204373 · DOI · Paper page
  53. Willis, 2004, Mutant p53 exerts a dominant negative effect by pre venting wild-type p53 from binding to the promoter of its target genes, Oncogene, 23, 2330, 10.1038/sj.onc.1207396 · DOI · Paper page
  54. Kern, 1992, Oncogenic forms of p53 inhibit p53-regulated gene expression, Science, 256, 827, 10.1126/science.1589764 · DOI · Paper page

Cited by

See all 45

Metadata

Authors
Aramayo, R., Sherman, M. B., Brownless, K., Lurz, R., Okorokov, A. L., & Orlova, E. V.
Venue
Nucleic Acids Research
Published
2011-07-15
Volume
39
Issue
20
Pages
8960-8971
ISSN
  • 1362-4962
  • 0305-1048
Cited by
45
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.